MCID: DNY001
MIFTS: 70

Denys-Drash Syndrome malady

Genetic diseases, Rare diseases, Nephrological diseases, Reproductive diseases, Endocrine diseases, Fetal diseases, Cancer diseases categories

Summaries for Denys-Drash Syndrome

About this section


NIH Rare Diseases:43 Denys-drash syndrome is a condition that affects the kidneys and genitalia. kidney disease typically begins in the first few months of life, often leading to kidney failure in childhood. in addition, up to 90 percent of people with this condition develop a rare form of kidney cancer known as wilms tumor. males with denys-drash syndrome have gonadal dysgenesis, a condition in which the external genitalia do not look clearly male or clearly female (ambiguous genitalia) or the genitalia appear to be completely female. the testes are also undescended, meaning that they remain in the pelvis, abdomen, or groin. affected females usually have normal genitalia. for this reason, females with this condition may be diagnosed with isolated nephrotic syndrome. denys-drash syndrome is caused by mutations in the wt1 gene. this condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. however, most cases result from new mutations in the gene and occur in people with no history of the disorder in their family. last updated: 10/28/2013

MalaCards based summary: Denys-Drash Syndrome, also known as drash syndrome, is related to wilms tumor and gonadal dysgenesis, and has symptoms including male pseudohermaphroditism, proteinuria and nephrotic syndrome. An important gene associated with Denys-Drash Syndrome is WT1 (Wilms tumor 1), and among its related pathways are TGF-beta/Smad Signaling and Nephrin interactions. The compounds dmrt and hydroxysteroid have been mentioned in the context of this disorder. Affiliated tissues include kidney and testes, and related mouse phenotypes are renal/urinary system and respiratory system.

Disease Ontology:10 An autosomal dominant disease that is characterized by the association of diffuse mesangial sclerosis (dms), male pseudohermaphroditism with a 46,xy karyotype, and nephroblastoma that derives from an abnormality in the wt1 gene (wilms' tumor suppressor gene).

Genetics Home Reference:23 Denys-Drash syndrome is a condition that affects the kidneys and genitalia.

Wikipedia:65 Denys?Drash syndrome (DDS) or Drash syndrome is very rare disorder or syndrome characterized by gonadal... more...

Description from OMIM:47 194080

Aliases & Classifications for Denys-Drash Syndrome

About this section
Sources:
47OMIM, 32LifeMap Discovery®, 10Disease Ontology, 11diseasecard, 43NIH Rare Diseases, 22GeneTests, 23Genetics Home Reference, 12DISEASES, 45Novoseek, 49Orphanet, 24GTR, 62UMLS, 35MeSH, 57SNOMED-CT, 40NCIt, 36MESH via Orphanet, 28ICD10 via Orphanet, 63UMLS via Orphanet
See all sources

Denys-Drash Syndrome, Aliases & Descriptions:

Name: Denys-Drash Syndrome 47 32 10 11 43 22 23 12 45 49 62
Drash Syndrome 43 23 49 24
Wilms Tumor and Pseudohermaphroditism 43 23 49
Nephropathy, Wilms Tumor, and Genital Anomalies 43 23
 
Nephropathy Associated with Male Pseudohermaphroditism and Wilms' Tumor 43
Pseudohermaphroditism, Nephron Disorder and Wilms' Tumor 43
Dds 23


Classifications:



Characteristics (Orphanet epidemiological data):

49
denys-drash syndrome:
Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal


External Ids:

OMIM47 194080
Disease Ontology10 DOID:3764
NCIt40 C84668
SNOMED-CT57 236385009
Orphanet49 220
MESH via Orphanet36 D030321
ICD10 via Orphanet28 N04.1
UMLS via Orphanet63 C0950121

Related Diseases for Denys-Drash Syndrome

About this section

Diseases related to Denys-Drash Syndrome via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 87)
idRelated DiseaseScoreTop Affiliating Genes
1wilms tumor31.1WT1, CD2AP, NPHS2, NPHS1, NR5A1, PDGFA
2gonadal dysgenesis30.8NR5A1, WT1
3diffuse mesangial sclerosis30.7NPHS2, PAX2, NPHS1, WT1
4nephrotic syndrome30.7CD2AP, NPHS1, NPHS2, PAX2, WT1
5glomerulosclerosis30.6PDGFA, NPHS1, NPHS2, WT1, CD2AP, TGFB1
6kidney disease30.5WT1, PAX2, TGFB1
7nephrosis30.2NPHS1, NPHS2
8glomerulonephritis30.1NPHS1, TGFB1, NPHS2, CD2AP
9gonadoblastoma10.5
10pseudohermaphroditism10.5
11coronary artery disease10.3
12artery disease10.3
13endotheliitis10.3
14hemolytic-uremic syndrome10.3
15congenital diaphragmatic hernia10.3
16mixed gonadal dysgenesis10.3
17pyloric stenosis10.3
18septate vagina10.3
19myocardial infarction10.3
20leprosy10.2
21obesity10.1
22dentin dysplasia, type i, with microdontia and misshapen teeth10.1
23acute myocardial infarction10.1
24lepromatous leprosy10.1
25developmental disabilities10.1
26end stage renal failure10.1
27intussusception10.1
28nephritis10.1
2946xy sex reversal 310.1NR5A1
30frasier syndrome10.1WT1
31sex cord-gonadal stromal tumor10.0WT1, NR5A1
32abrikosov's tumor10.0NR5A1, WT1
33hypospadias10.0SRD5A1, NR5A1, WT1
34cryptorchidism10.0NR5A1, SRD5A1, WT1
35congenital adrenal hyperplasia10.0SRD5A1, NR5A1
36addison's disease10.0NR5A1, WT1
37pallister-hall syndrome10.0MECOM, KLF10
38leydig cell tumor10.0SRD5A1, NR5A1
39nail-patella syndrome10.0NPHS2, PAX2, CD2AP
40ureteral obstruction10.0PDGFA, TGFB1
41klinefelter's syndrome10.0SRD5A1, NR5A1
42lipoid nephrosis10.0NPHS2, CD2AP, NPHS1
43gingival overgrowth10.0TGFB1, SRD5A1
44membranous glomerulonephritis, antenatal10.0NPHS1, NPHS2, CD2AP
45congenital nephrotic syndrome finnish type10.0CD2AP, WT1, NPHS1, NPHS2
46focal segmental glomerulosclerosis10.0NPHS1, NPHS2, PAX2, WT1, CD2AP
47primary hyperoxaluria10.0NPHS2, PAX2, NPHS1, CD2AP, WT1
48osteosarcoma, somatic10.0KLF10, TGFB1, SAFB, PDGFA
49microvascular complications of diabetes 310.0NPHS2, NPHS1, TGFB1, PDGFA
50myeloid leukemia10.0WT1, TGFB1, MECOM

Graphical network of the top 20 diseases related to Denys-Drash Syndrome:



Diseases related to denys-drash syndrome

Symptoms for Denys-Drash Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

194080

Clinical features from OMIM:

194080

Symptoms:

 49 (show all 7)
  • renal disease/nephropathy
  • nephrotic syndrome
  • proteinuria
  • male pseudohermaphrodism/lack of virilisation
  • nephroblastoma/wilms tumor
  • chronic arterial hypertension
  • mixed gonadal dysgenesis

HPO human phenotypes related to Denys-Drash Syndrome:

(show all 24)
id Description Frequency HPO Source Accession
1 male pseudohermaphroditism hallmark (90%) HP:0000037
2 proteinuria hallmark (90%) HP:0000093
3 nephrotic syndrome hallmark (90%) HP:0000100
4 nephropathy hallmark (90%) HP:0000112
5 nephroblastoma (wilms tumor) hallmark (90%) HP:0002667
6 hypertension typical (50%) HP:0000822
7 gonadal dysgenesis occasional (7.5%) HP:0000133
8 autosomal dominant inheritance HP:0000006
9 ambiguous genitalia, male HP:0000033
10 male pseudohermaphroditism HP:0000037
11 ambiguous genitalia, female HP:0000061
12 focal segmental glomerulosclerosis HP:0000097
13 nephrotic syndrome HP:0000100
14 nephropathy HP:0000112
15 gonadal dysgenesis HP:0000133
16 ovarian gonadoblastoma HP:0000149
17 congenital diaphragmatic hernia HP:0000776
18 hypertension HP:0000822
19 somatic mutation HP:0001428
20 diffuse mesangial sclerosis HP:0001967
21 nephroblastoma (wilms tumor) HP:0002667
22 gonadal tissue inappropriate for external genitalia or chromosomal sex HP:0003248
23 stage 5 chronic kidney disease HP:0003774
24 true hermaphroditism HP:0010459

Drugs & Therapeutics for Denys-Drash Syndrome

About this section

Drug clinical trials:

Search ClinicalTrials for Denys-Drash Syndrome

Search NIH Clinical Center for Denys-Drash Syndrome

Genetic Tests for Denys-Drash Syndrome

About this section

Genetic tests related to Denys-Drash Syndrome:

id Genetic test Affiliating Genes
1 Denys-Drash Syndrome22 WT1
2 Drash Syndrome24

Anatomical Context for Denys-Drash Syndrome

About this section

MalaCards organs/tissues related to Denys-Drash Syndrome:

33
Kidney, Testes

LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine

Cells/anatomical compartments in embryo or adult related to Denys-Drash Syndrome:
id TissueAnatomical CompartmentCell Relevance
1 KidneyMetanephric MesenchymeMetanephric Mesenchyme Cells Potential therapeutic candidate, affected by disease

Animal Models for Denys-Drash Syndrome or affiliated genes

About this section

Publications for Denys-Drash Syndrome

About this section

Articles related to Denys-Drash Syndrome:

(show top 50)    (show all 76)
idTitleAuthorsYear
1
Clinical features and an atypical WT1 mutant site in a child with incomplete Denys-Drash syndrome. (24625882)
2014
2
An unusual presentation of denys-drash syndrome due to bigenic disease. (24379226)
2014
3
Denys-Drash syndrome, septated vagina and low level of anti-Mullerian hormone in male neonate. (25077094)
2014
4
A familial WT1 mutation associated with incomplete Denys-Drash syndrome. (23715653)
2013
5
Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy. (23729537)
2013
6
A novel WT1 heterozygous nonsense mutation (p.K248X) causing a mild and slightly progressive nephropathy in a 46,XY patient with Denys-Drash syndrome. (21559934)
2011
7
Clinical pictures and novel mutations of WT1-associated Denys-Drash syndrome in two Chinese children. (21851196)
2011
8
A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. (19797313)
2010
9
The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome. (20562648)
2010
10
Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome. (18197048)
2008
11
Denys-Drash syndrome and congenital diaphragmatic hernia: another case with the 1097G &gt; A(Arg366His) mutation. (18203154)
2008
12
Effects on kidney disease, fertility and development in mice inheriting a protein-truncating Denys-Drash syndrome allele (Wt1tmT396). (18040647)
2008
13
Mixed gonadal dysgenesis and Denys-Drash syndrome: urologists should screen for nephrotic syndrome. (18163932)
2007
14
Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome. (17267748)
2007
15
A novel WT1 missense mutation presenting with Denys-Drash syndrome and cortical atrophy. (16303781)
2006
16
Denys-Drash syndrome (DDS). (16823575)
2006
17
Hydrothorax in a patient with Denys-Drash syndrome associated with a diaphragmatic defect. (16932893)
2006
18
Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. (15910385)
2005
19
A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. (15503171)
2005
20
Denys-Drash syndrome. (15758579)
2005
21
Denys-Drash syndrome. (15026863)
2004
22
A novel mutation of WT1 exon 9 in a patient with Denys-Drash syndrome and pyloric stenosis. (15349765)
2004
23
The dysregulated glomerular cell growth in Denys-Drash syndrome. (15232745)
2004
24
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. (12915483)
2003
25
A necropsy case of Denys-Drash syndrome with a WT1 mutation in exon 7. (12161615)
2002
26
Wilms tumor in a pediatric renal transplant recipient with unexpected Denys-Drash syndrome. (12493420)
2002
27
A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. (12138137)
2002
28
Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome. (11519891)
2001
29
Pulmonary dysplasia, Denys-Drash syndrome and Wilms tumor 1 gene mutation in twins. (11322369)
2001
30
Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome. (10738002)
2000
31
Hemolytic uremic syndrome associated with Denys-Drash syndrome. (11045393)
2000
32
A novel missense mutation of the WT1 gene causing Denys-Drash syndrome with exceptionally mild renal manifestations. (10799199)
2000
33
A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. (10077614)
1999
34
Unexpected Wilms' tumor in a pediatric renal transplant recipient: suspected Denys-Drash syndrome. (10371996)
1999
35
Renal transplantation in the management of bilateral Wilms' tumour (BWT) and of Denys-Drash syndrome (DDS). (9641183)
1998
36
No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome. (9681076)
1998
37
Regulation of renal EGF receptor expression is normal in Denys-Drash syndrome. (9291179)
1997
38
Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation. (9125334)
1996
39
A novel mutation H373Y in the Wilms' tumor suppressor gene, WT1, associated with Denys-Drash syndrome. (8956030)
1996
40
Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases? (7556327)
1995
41
Aberrant proteoglycan composition of the glomerular basement membrane in a patient with Denys-Drash syndrome. (8808212)
1995
42
WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. (7959750)
1994
43
Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome. (8281163)
1993
44
A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome. (8281164)
1993
45
A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. (8098976)
1993
46
A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. (8381368)
1993
47
Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. (8229473)
1993
48
Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. (8388765)
1993
49
Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. (1338905)
1992
50
Inherited WT1 mutation in Denys-Drash syndrome. (1327525)
1992

Variations for Denys-Drash Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Denys-Drash Syndrome:

64 (show all 24)
id Symbol AA change Variation ID SNP ID
1WT1p.Cys330TyrVAR_007743
2WT1p.Cys360GlyVAR_007744
3WT1p.Arg366CysVAR_007745
4WT1p.Arg366HisVAR_007746
5WT1p.His373GlnVAR_007747
6WT1p.Arg394TrpVAR_007750
7WT1p.Asp396AsnVAR_007751
8WT1p.Asp396GlyVAR_007752
9WT1p.Met342ArgVAR_015054
10WT1p.Cys355TyrVAR_015055
11WT1p.His373TyrVAR_015056
12WT1p.His377ArgVAR_015057
13WT1p.Cys385ArgVAR_015058
14WT1p.Cys388PheVAR_015059
15WT1p.Arg394GlnVAR_015061
16WT1p.Leu398ProVAR_015062
17WT1p.Cys360TyrVAR_043800
18WT1p.Arg366LeuVAR_043802
19WT1p.Gln369ProVAR_043803
20WT1p.Cys388TyrVAR_043806
21WT1p.Arg394ProVAR_043808
22WT1p.Asp396TyrVAR_043809
23WT1p.His401TyrVAR_043811
24WT1p.His405ArgVAR_043812

Clinvar genetic disease variations for Denys-Drash Syndrome:

7 (show all 11)
id Gene Variation Type Significance SNP ID Assembly Location
1WT1NM_000378.4(WT1): c.1333C> T (p.Arg445Trp)single nucleotide variantPathogenicrs121907900GRCh37Chr 11, 32413566: 32413566
2WT1NM_000378.4(WT1): c.1250G> A (p.Arg417His)single nucleotide variantPathogenicrs121907901GRCh37Chr 11, 32414250: 32414250
3WT1NM_000378.4(WT1): c.1340A> G (p.Asp447Gly)single nucleotide variantPathogenicrs121907902GRCh37Chr 11, 32413559: 32413559
4WT1NM_000378.4(WT1): c.1339G> A (p.Asp447Asn)single nucleotide variantPathogenicrs28941778GRCh37Chr 11, 32413560: 32413560
5WT1NM_000378.4(WT1): c.1334G> C (p.Arg445Pro)single nucleotide variantPathogenicrs121907903GRCh37Chr 11, 32413565: 32413565
6WT1NM_000378.4(WT1): c.1142G> A (p.Cys381Tyr)single nucleotide variantPathogenicrs121907904GRCh37Chr 11, 32417859: 32417859
7WT1NM_001198551.1(WT1): c.787+14G> Asingle nucleotide variantPathogenicGRCh38Chr 11, 32391967: 32391967
8WT1NM_000378.4(WT1): c.1282C> T (p.His428Tyr)single nucleotide variantPathogenicrs28942089GRCh37Chr 11, 32414218: 32414218
9WT1NM_000378.4(WT1): c.1231T> G (p.Cys411Gly)single nucleotide variantPathogenicrs121907905GRCh37Chr 11, 32414269: 32414269
10WT1NM_000378.4(WT1): c.1237C> T (p.Arg413Ter)single nucleotide variantPathogenicrs121907906GRCh37Chr 11, 32414263: 32414263
11WT1NM_000378.4(WT1): c.1272C> G (p.His424Gln)single nucleotide variantPathogenicrs121907907GRCh37Chr 11, 32414228: 32414228

Expression for genes affiliated with Denys-Drash Syndrome

About this section

Search GEO for disease gene expression data for Denys-Drash Syndrome.

Pathways for genes affiliated with Denys-Drash Syndrome

About this section

Pathways related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.9PAX2, TGFB1
29.9NPHS1, CD2AP
39.7PDGFA, TGFB1
49.6CD2AP, NPHS1, NPHS2
59.5PDGFA, WT1, TGFB1
6
Show member pathways
MAPK signaling pathway38
9.3TGFB1, MECOM, PDGFA

Compounds for genes affiliated with Denys-Drash Syndrome

About this section

Compounds related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

(show all 23)
idCompoundScoreTop Affiliating Genes
1dmrt4510.3WT1, NR5A1
2hydroxysteroid4510.0SRD5A1, NR5A1
3puromycin aminonucleoside459.9NPHS2, CD2AP, NPHS1
4calcitriol45 61 26 1312.6SRD5A1, WT1, TGFB1
5sildenafil30 45 51 26 1313.6SRD5A1, TGFB1
6creatinine459.6TGFB1, NPHS1, NPHS2, WT1
7ribonucleic acid459.5PDGFA, TGFB1, NR5A1, WT1
812-o-tetradecanoylphorbol 13-acetate459.5WT1, TGFB1, PDGFA
9progesterone45 30 61 26 1313.3NR5A1, PDGFA, SRD5A1, WT1
10glutamine459.1WT1, SRD5A1, SAFB, TGFB1
11indomethacin45 30 61 1312.1TGFB1, NPHS1, SRD5A1
12vegf459.0SRD5A1, PDGFA, NPHS1, TGFB1, WT1
13testosterone45 61 26 1312.0WT1, NR5A1, SRD5A1, SAFB
14dexamethasone45 51 30 1312.0NPHS1, TGFB1, SRD5A1, PDGFA
15oligonucleotide458.9TGFB1, PDGFA, NR5A1, WT1, SAFB
16lipid458.8NPHS2, NPHS1, NR5A1, SAFB, CD2AP
17serine458.7NPHS1, PAX2, SAFB, NR5A1, TGFB1, WT1
18tyrosine458.6PDGFA, SAFB, PAX2, WT1, NPHS2, NPHS1
19zinc45 269.6PDGFA, KLF10, WT1, SAFB, MECOM, NR5A1
20vitamin d458.5WT1, SAFB, TGFB1, SRD5A1, PDGFA, NR5A1
21steroid458.4WT1, SRD5A1, NPHS2, NR5A1, NPHS1, SAFB
22estrogen458.2TGFB1, SAFB, SRD5A1, PDGFA, NR5A1, KLF10
23retinoic acid45 269.2PDGFA, TGFB1, SAFB, SRD5A1, NR5A1, NPHS1

GO Terms for genes affiliated with Denys-Drash Syndrome

About this section

Cellular components related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1slit diaphragmGO:003605710.0NPHS1, NPHS2
2microvillusGO:00059029.7TGFB1, PDGFA
3protein complexGO:00432349.4NPHS1, NPHS2, PAX2
4nuclear speckGO:00166079.3MECOM, SRSF6, WT1
5nucleusGO:00056346.8TGFB1, PAX2, SAFB, SRSF6, MECOM, KLF10

Biological processes related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

(show all 24)
idNameGO IDScoreTop Affiliating Genes
1metanephric epithelium developmentGO:007220710.4PAX2, WT1
2negative regulation of female gonad developmentGO:0200019510.3NR5A1, WT1
3mesenchymal to epithelial transitionGO:006023110.3WT1, PAX2
4positive regulation of male gonad developmentGO:0200002010.3WT1, NR5A1
5metanephric mesenchyme developmentGO:007207510.3WT1, PAX2
6glomerular basement membrane developmentGO:003283610.3WT1, NPHS1
7tissue developmentGO:000988810.2WT1, NR5A1
8adrenal gland developmentGO:003032510.2NR5A1, WT1
9negative regulation of programmed cell deathGO:004306910.2MECOM, PAX2
10positive regulation of branching involved in ureteric bud morphogenesisGO:009019010.1TGFB1, PAX2
11sex determinationGO:000753010.1SRD5A1, WT1
12camera-type eye developmentGO:004301010.1WT1, PAX2
13protein kinase B signalingGO:004349110.0TGFB1, PAX2
14ureteric bud developmentGO:00016579.9TGFB1, WT1
15hormone metabolic processGO:00424459.9NR5A1, SAFB
16excretionGO:00075889.8NPHS2, NPHS1
17positive regulation of MAP kinase activityGO:00434069.7TGFB1, PDGFA
18transforming growth factor beta receptor signaling pathwayGO:00071799.7PDGFA, TGFB1, KLF10
19cell-cell signalingGO:00072679.6KLF10, NR5A1, PDGFA
20negative regulation of transcription, DNA-templatedGO:00458929.6PAX2, MECOM, WT1, TGFB1
21negative regulation of transcription from RNA polymerase II promoterGO:00001229.6PAX2, TGFB1, WT1, KLF10
22positive regulation of transcription, DNA-templatedGO:00458939.5WT1, TGFB1, PAX2, MECOM
23inner ear developmentGO:00488399.4TGFB1, PDGFA
24positive regulation of transcription from RNA polymerase II promoterGO:00459448.8PAX2, TGFB1, NR5A1, MECOM, WT1, SAFB

Molecular functions related to Denys-Drash Syndrome according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1C2H2 zinc finger domain bindingGO:007074210.0WT1, PAX2
2protein bindingGO:00055155.7WT1, TGFB1, PAX2, SAFB, MECOM, ZNF274

Products for genes affiliated with Denys-Drash Syndrome

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Denys-Drash Syndrome

About this section
4CDC
15ExPASy
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
58SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet